Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?

Ozsoy, Zehra; Ozdemir, Adem; Ekici, Mustafa; Bilgin, Emre; Kilic, Levent; Kiraz, Sedat; Saribas, Zeynep; Sener, Burçin; Karadag, Omer

Ozsoy, Zehra; Ozdemir, Adem; Ekici, Mustafa; Bilgin, Emre; Kilic, Levent; Kiraz, Sedat; Saribas, Zeynep; Sener, Burçin; Karadag, Omer.

Afiliação

Ozsoy Z; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey. dr.zehraduman@hotmail.com.
Ozdemir A; Department of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Ekici M; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Bilgin E; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Kilic L; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Kiraz S; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Saribas Z; Department of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Sener B; Department of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Karadag O; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

Rheumatol Int ; 43(8): 1445-1451, 2023 08.

Article em En | MEDLINE | ID: mdl-37005937

Assuntos

Antirreumáticos; Artrite Reumatoide; Produtos Biológicos; Tuberculose Latente; Tuberculose; Humanos; Tuberculose/tratamento farmacológico; Testes de Liberação de Interferon-gama/métodos; Tuberculose Latente/tratamento farmacológico; Artrite Reumatoide/tratamento farmacológico; Antirreumáticos/uso terapêutico; Imunossupressores/uso terapêutico; Produtos Biológicos/uso terapêutico; Teste Tuberculínico/métodos

Palavras-chave

Biologic/targeted-synthetic disease modifying anti-rheumatismal drugs; Immunosuppressive drugs; Interferon-gamma release assays; Latent tuberculosis reactivation; QuantiFERON-TB Gold Plus; Rheumatoid arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Tuberculose / Produtos Biológicos / Antirreumáticos / Tuberculose Latente Limite: Humans Idioma: En Revista: Rheumatol Int Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Turquia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google